Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 (denifanstat) once-daily oral tablet for treatment of ...

Jaguar Health announced that its product, cofelemer delayed-release tablets (Canalevia-CA1; Jaguar Health), received approved ...

Menopause can cause changes in your oral health. A dentist explains what changes you can expect from menopause and what you ...

You Need a Specific Dosage Form There may be situations where you need a specific dosage form of an unavailable drug. If a ...

A new proven protocol in which doxycycline is used to prevent sexually transmitted infections, called doxyPEP, has been an ...

He has been credited alongside Oral Roberts as one of the “two giants” of the post ... mp3 players and now computer tablets ...

companies can continue to make and market oral phenylephrine for nasal congestion, as the proposal is based on the drug’s ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

FDA approval of MIPLYFFA™ and product launch cap third quarter filled with multiple commercial and clinical development milestones Zevra received rare pediatric disease Priority Review Voucher Company ...

Dental professionals and consumers will be able to invest in sustainable oral care brand Pärla as it launches its first round ...

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.